Single-agent gemcitabine is active in previously treated metastatic breast cancer.

@article{Spielmann2001SingleagentGI,
  title={Single-agent gemcitabine is active in previously treated metastatic breast cancer.},
  author={Marc Spielmann and Antonio Llombart-Cussac and Sunil Kalla and Marc Espie and Mo{\"i}se Namer and Jean Marc Ferrero and V{\'e}ronique Di{\'e}ras and Pierre Fumoleau and Caroline Cuvier and Genevi{\`e}ve Perrocheau and Antonio Ponzio and Louis Kayitalire and Pierre Pouillart},
  journal={Oncology},
  year={2001},
  volume={60 4},
  pages={303-7}
}
BACKGROUND This phase II study was designed to assess the efficacy and safety of gemcitabine in patients with metastatic breast cancer (MBC) previously treated with an anthracycline- or anthracenedione-containing regimen as first-line therapy for metastatic disease. PATIENTS AND METHODS Forty-seven patients with MBC were enrolled in five French centers. Patients were eligible if they had received one prior chemotherapy regimen with an anthracycline or anthracenedione for metastatic disease… CONTINUE READING
54 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 54 extracted citations

Similar Papers

Loading similar papers…